Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Cash from Operations (2016 - 2025)

Mimedx (MDXG) has disclosed Cash from Operations for 15 consecutive years, with 24956000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 26.6% to 24956000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 74003000.0 through Dec 2025, up 10.24% year-over-year, with the annual reading at 74003000.0 for FY2025, 10.24% up from the prior year.
  • Cash from Operations hit 24956000.0 in Q4 2025 for Mimedx, down from 29329000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 29329000.0 in Q3 2025 to a low of 10223000.0 in Q1 2022.
  • Historically, Cash from Operations has averaged 8305700.0 across 5 years, with a median of 5638500.0 in 2024.
  • Biggest five-year swings in Cash from Operations: crashed 287.93% in 2022 and later surged 896.33% in 2024.
  • Year by year, Cash from Operations stood at 3232000.0 in 2021, then skyrocketed by 232.95% to 4297000.0 in 2022, then soared by 328.65% to 18419000.0 in 2023, then rose by 7.02% to 19712000.0 in 2024, then grew by 26.6% to 24956000.0 in 2025.
  • Business Quant data shows Cash from Operations for MDXG at 24956000.0 in Q4 2025, 29329000.0 in Q3 2025, and 14419000.0 in Q2 2025.